Your SlideShare is downloading. ×
0
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Principles of immunodetection
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Principles of immunodetection

795

Published on

Published in: Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
795
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
16
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Principles ofimmunodetection
  • 2. Aims and Objectives• Basis of antigen-antibody interaction• Conceptualise the different techniquesbased on this interaction• Examples of clinical application• Research problems requiringimmunoanalyses
  • 3. Role of antibodies• Protect against– Viral infections– Bacterial infections– Foreign bodies• Antigens• Deleterious in– Autoimmune diseases• Reumathoid arthritis Lupus• Type 1 diabetes Croh’n disease– Graft rejection
  • 4. Antigen-antibody interaction• Antigen: foreign molecules that generate antibodies or anysubstance that can be bound specifically by an antibodymolecule– Proteins, sugars, lipids or nucleic acids– Natural or synthetic• Antibody: molecules (protein) responsible for specificrecognition and elimination (neutralization) of antigens– Different structures (7-8 classes in mammals)– Powefull research tools for basic research, clinical applications anddrug design
  • 5. Antigenic determinants• An antibody will recognize– Epitope: defined segment of an antigen– Immunoreactivity of epitopes may depend on primary,secondary, tertiary or quaternary structure of an antigen– Variability of epitopes depends on the species• Antibodies are antigen themselves
  • 6. Nature of binding forces• Hydrogen bonding– Results from the formation of hydrogen bridges between appropriate atoms• Electrostatic forces– Are due to the attraction of oppositely charged groups located on two protein sidechains• Van der Waals bonds– Are generated by the interaction between electron clouds (oscillating dipoles)• Hydrophobic bonds– Rely upon the association of non-polar, hydrophobic groups so that contact with watermolecules is minimized (may contribute up to half the total strength of the antigen-antibodybond)
  • 7. Antigen-antibody binding
  • 8. Structure of an antibody
  • 9. Antigen-antibody affinityThe affinity with which antibody binds antigen results from a balancebetween the attractive and repulsive forces. A high affinity antibody impliesa good fit and conversely, a low affinity antibody implies a poor fit and alower affinity constant
  • 10. Generation of an antibody:antigen processing
  • 11. B cell activation
  • 12. Antibody and VDJ recombination
  • 13. Generation of antibodies:polyclonal vs monoclonal• Host animals ca be used to raise antibodiesagainst a given antigen• Slected clones from a polyclonal each recognizinga single epitope can be fused to a tumor cell(hybridoma) to proliferate indefinitely
  • 14. Laboratory use of antibodies• Quantitation of an antigen– RIA, Elisa• Identification and characterization of protein antigens– Immunoprecipitation– Western blotting• Cell surface labelling and separation• Localisation of antigens within tissues or cells• Expression librairies• Phage display
  • 15. Antigen-antibody interaction:concentration dependenceConcentration of unknown samples are determined from a standard curve
  • 16. • General equation for adose response curve• It shows response as afunction of the logarithmof concentration• X is the logarithm ofagonist concentrationand Y is the response• Log EC50 is thelogarithm of the EC50(effective concentration,50%)• IC50 (inhibitory conc.)Sigmoidal dose response curve10%90%
  • 17. • Antibody antigen interaction– RIA, ELISA– Ligand receptor interaction– Growth factors– Hormones• Activity of chemotherapeutics• Enzymatic inhibitorsDoses response curves
  • 18. Cross reactivity
  • 19. One and two sites competition
  • 20. Detection principles• Radiolabelled isotopes– 125I, 14C, 32P, 35S• Enzymes– Peroxydase• Chromophores– Fluorogenic probes, fluorescent proteins
  • 21. Peroxydase reaction
  • 22. RIA: radio immuno assay
  • 23. RIA interference
  • 24. Elisa: Enzyme-linked immunosorbent assay
  • 25. Sandwich Elisa
  • 26. Western blotting
  • 27. Two dimensional electrophoresispHMolecularweightkDa1st dimension 2nd dimension
  • 28. ImmunoprecipitationWestern Blotting
  • 29. Immunohistochemistry
  • 30. Clinical use of antibodies• Diagnostic– Detection of peptides and other molecules in various diseases• Endocrine diseases: hyperinsulinemia, diabetes, hyperparatyroidism• Tumor antigens (p53 tumor suppressor, PSA, a-foetoprotein)• Antibodies against viral proteins (AIDS, hepatitis)• Therapeutic– Neutralizing antibodies• Anti-Erbb2 for breast and ovarian cancer• Anti-CD20 for B-cell non-Hodgkins lymphoma• Experimental– Drug screening (phage display)
  • 31. Detection of HIV proteins by WBgp160 viral envelope precursor (env)gp120 viral envelope protein (env) binds to CD4p31 Reverse Transcriptase (pol)p24 viral core protein (gag)
  • 32. • Phosphorylation and dephosphorylation affectthe structure and activity of proteins• Cellular signalling is characterized by cascadesof phosphorylation• Kinases and phosphatases maintainphosphorylated/dephosphorylated state ofproteins• Phospho/Tyrosine/Threonine/ SerinePhosphospecific antibodies to studycellular signaling
  • 33. DNA damage inducible cascades
  • 34. Phosphospecific detections
  • 35. Cytoskeleton TranslationERK5ELK1/TCFMEF2A-CATF2 NFAT4, NFATc1MAX CHOP/GADD153Transcription Factorsc-junSAPKsInhibitsnucleartranslocationEffectorKinasesMAPKAP-K2/3PRAK MSK1/2 MNK1/2 RSKsp38sHSP25/27CREB, HistoneH3, HMG14eIF4EChromatinRemodellingASK1Tpl-2 MEKK2MEKK3MEKK1RAF1SEK1MKK7aMKK3aMKK6MEK5MEK1/2ERK1/2MAP3KsMAPKsMEKsaInhibited byCSAIDS(Cytokine-SuppressiveAnti-InflammatoryDrugs)eg SB203580Synergize inSAPKactivationp53PP2B/CalcineurinMKP1CDC25BCDC2WIP1Pac1Pac1MKP5MKP4MKP2MKP3M3/6(Hematopoietic only)Inhibited byPD98059(MEK2)c-AblRac1dsDNAbreaksInflammatory cytokinesATMMEKK4TAK1TAOsMLKsUV,MMSPyk2 LynSHPTP1Cdc42HsKinases and signal transduction
  • 36. FRET:Fluorescence resonance energy transfer
  • 37. Localization of BFP- and RFP-C/EBP protein expressed in mouse 3T3 cells using2p-FRET microscopy. The doubly expressed cells (BFP-RFP-C/EBP) were excitedby 740 nm and the donor (A) and acceptor (B) images of proteins localized in thenucleus of a single living cell were acquired by single scanLocalization of CEBP by FRET
  • 38. cDNA librairies
  • 39. Expression librairies
  • 40. Phage display
  • 41. Phage display: Ab productionOriginally developped to produce monoclonalantibodies, phage display is a simple yetpowerful technology that is used to rapidlycharacterize protein-protein interactions fromamongst billions of candidates. This widelypracticed technique is used to map antibodyepitopes, create vaccines and to engineerpeptides, antibodies and other proteins as bothdiagnostic tools and as human therapeutics
  • 42. Clinical applications• Neutralizing antibodies– Antidotes and antivenin (snake & spider bites)– Tumor antigens ErbB-2, melanoma and T-cell leukemia,antibodies coupled to toxins– Autoimmune antibodies, cytokines TNF-a– Antisera aigainst virus, bateria and toxins (vaccine)– Anti IgE and IgM for allegies (experimental)– Quantitation of blood peptides (hormones metabolites)• Activating antibodies– Complement activating for uncontrolled bleeding (hemophilia)
  • 43. Concentration of serum peptides• Blood levels of:– Hormones– Antibodies– Enzymes– Metabolites
  • 44. • Identification of signaling pathways– Protein modifications– Signaling partners• Activity of drugs (lead compounds)• Lack of specific molecules– Specific ligands (side effects)– New antibodiesResearch problems requiringimmunoanalyses
  • 45. The problems of chemotherapyChemotherapy/radiotherapySensorsTransducersCytoplasmic/Nuclear effectorsChromatinStructureTranscriptionDNA repairCell cyclecheckpointsApoptosisDrug resistance arisingfrom sensor/transducerdefectsDrug resistance arisingfrom effector defectsDNA DamageDrug resistance arisingfrom altered drugdelivery to target

×